Below is a three month price history chart comparing the stock performance of VRX, versus MCK and AGN.

FORBES: Top Buys by Top Brass: Chief Executive Officer Pearson's $6M Bet on VRX

According to the ETF Finder at ETF Channel, VRX makes up 3.84% of the Pharmaceutical HOLDRS ETF ( AMEX: PPH) which is trading lower by about 1.4% on the day Monday.

FORBES: Top Buys by Top Brass: Chief Executive Officer Pearson's $6M Bet on VRX

Valeant Pharmaceuticals (VRX) is commercializing the treatment.

FORBES: Pharma News: Alexza Pharmaceuticals, YM BioSciences